D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −17,153−100.0% | Sold out | Holders |
| Q3 2025 | 17,153 | $77.7K | <0.1% | −9,599−35.9% | Reduced | Holders |
| Q2 2025 | 26,752 | $57.5K | <0.1% | −192−0.7% | Reduced | Holders |
| Q1 2025 | 26,944 | $117.7K | <0.1% | −20,670−43.4% | Reduced | Holders |
| Q4 2024 | 47,614 | $222.4K | <0.1% | +47,614 | New | Holders |